Personalized swallowing rehabilitation program for post-surgical dysphagia in oral cancer patients: a randomized controlled trial [0.03%]
头颈肿瘤术后吞咽障碍患者个体化康复方案的疗效研究：随机对照试验
Yanhong Zhang,Hua Chen,Jie Zhou et al.
Yanhong Zhang et al.
Background: Dysphagia following oral cancer ablative surgery with free flap reconstruction significantly impairs quality of life, yet personalized rehabilitation approaches remain understudied. This randomized controlled ...
Front-line treatment approaches in multiple myeloma: real-world data from a community-based oncology network [0.03%]
社区肿瘤网络中的多发性骨髓瘤初治患者的治疗模式及真实世界数据
R Steve Paulson,Santosh Gautam,Rohan Medhekar et al.
R Steve Paulson et al.
Background: The front-line (1L) treatment landscape for newly diagnosed multiple myeloma (NDMM) is rapidly evolving with guidelines endorsing triplet and quadruplet regimens as new standard-of-care. Despite this, real-wor...
Gut microbiome restructuring in laryngeal squamous cell carcinoma identifies stable microbial biomarkers with diagnostic potential [0.03%]
喉部鳞状细胞癌中的肠道微生物组重建鉴定出具有诊断潜力的稳定型微生物标志物
Jiaming Zhang,Jingtai Zhi,Jianxin Li et al.
Jiaming Zhang et al.
Background: Alterations in the gut microbiota have been reported in various malignancies, but its role in laryngeal squamous cell carcinoma (LSCC) remains unclear. ...
Ultrasound-guided microwave ablation for small thyroid nodules with RAS mutation: a pilot study [0.03%]
甲状腺RAS突变小结节射频消融治疗的超声引导微波消融疗法：一项前瞻性研究
Fengyun Cheng,Yujiang Li,Ruixue Huang et al.
Fengyun Cheng et al.
Objective: The clinical management of RAS-mutated nodules faces significant challenges. This study aimed to explore the efficacy of microwave ablation (MWA) for the treatment of thyroid nodules ≤ 2 cm with isolated RAS g...
Case Report: A case of type II cryoglobulinemia secondary to diffuse large B-cell lymphoma [0.03%]
病例报告：弥漫性大B细胞淋巴瘤继发II型冷球蛋白血症一例
Cuiping Mao,Xiaohe Hao
Cuiping Mao
Background: Diffuse Large B-Cell Lymphoma (DLBCL) represents the most prevalent subtype of Non-Hodgkin Lymphoma (NHL). Cryoglobulinemia results from reversible precipitation of serum immunoglobulin complexes at low temper...
VA/VHAG alternating consolidation regimen combined with umbilical cord blood and mesenchymal stem cell infusion for the treatment of high-risk MDS patients who are unfit for transplantation: a case report and literature review [0.03%]
低移植强度下的VA/VHAG交替诱导及Consolidation方案联合脐血和间充质干细胞输注治疗高危不适合移植MDS患者：1例报告及文献复习
Qixin Sun,Zhenzhen Wen,Yanying Ling et al.
Qixin Sun et al.
The only treatment option for high-risk MDS patients unfit for transplantation is continuous treatment with a hypomethylating agent (HMA). In this context, some new combination HMA regimens and other drugs with different mechanisms of actio...
Aerobic glycolysis in bladder cancer: research advances and targeted therapy potential [0.03%]
膀胱癌有氧糖酵解的研究进展及靶向治疗潜力
Mengyuan Pan,Tianyi Tao,Dehui Kong et al.
Mengyuan Pan et al.
Bladder cancer (BCa) is one of the most common malignant tumors of the urinary system. Its frequent recurrence, high metastatic potential, and resistance to therapies pose major obstacles to achieving long-term patient survival. As a core f...
Glioblastoma recurrence followed by newly diagnosed small cell lung cancer: a case report on personalized concurrent chemoradiotherapy and therapeutic considerations [0.03%]
胶质母细胞瘤复发后新诊断的小细胞肺癌：个性化同步放化疗及治疗考量的病例报告
Xue Ren,Feng Shang,Defu Yang et al.
Xue Ren et al.
Glioblastoma (GBM) and small cell lung cancer (SCLC) are both highly aggressive malignancies, and their co-occurrence is extremely rare, posing significant therapeutic challenges. We report a 50-year-old male diagnosed with right temporal G...
Critical considerations in the administration of antineoplastic therapy for patients with malignant solid tumors undergoing hemodialysis [0.03%]
透析肿瘤患者抗肿瘤药物治疗的思考
Jun Li,Qi Ke,Wen-Qing Lv et al.
Jun Li et al.
Patients with chronic kidney disease exhibit a higher risk of developing malignancies, and among those with end-stage renal disease (ESRD) on dialysis, approximately 7% are diagnosed with new-onset tumors within five years. Patients with ES...
Metabolic symbiosis and competition: the dual nature of TAM-tumor cell cross-talk in tumor progression [0.03%]
代谢共生与竞争：TAM-肿瘤细胞相互作用的双重性质促进肿瘤进展
Chaokai Ba,Shizheng Tong,Zefan Wang et al.
Chaokai Ba et al.
Cancer cells and tumor associated macrophages (TAMs) engage in a sophisticated metabolic symbiosis within the tumor microenvironment (TME), where reciprocal metabolite exchange drives immune evasion and malignant progression. This review po...